Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Fort Sam Houston, Texas Clinical Trials

A listing of Fort Sam Houston, Texas clinical trials actively recruiting patient volunteers.

RESULTS

Found (24) clinical trials

ICON  Early  Phase  Services  is  conducting  a  research  study  for  healthy  adults  ages 18-65. This study is being  done  to test a  potential treatment for neurodegenerative diseases  (e.g.,  Parkinson's  and Alzheimer's). Vital  signs,  ECGs,  physical  examinations  and  pregnancy,  drug  and  alcohol  screens will be performed.  Blood  and  urine  samples  will ...

Phase

1.83 miles

Learn More »

ICON Early Phase Services is conducting a research study for healthy adults ages 18-55. This study is being done to test the interaction of the study drugs.  This study will help in the development of a potential treatment for pulmonary arterial hypertension (PAH). Vital signs, ECGs, physical examinations and pregnancy, ...

Phase

1.83 miles

Learn More »

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

This is a Phase 2b, multicenter, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with moderately to severely active, autoantibody-positive systemic lupus erythematosus (SLE). Approximately 500 adult subjects with SLE will be randomized in a 1:1:1:1:1 ratio ...

Phase

2.29 miles

Learn More »

Efficacy & Safety of TD-1473 in Ulcerative Colitis

This protocol consists of 3 separate studies: an 8-week Phase 2b dose-finding induction study, an 8-week dose-confirming Phase 3 induction study, and a 44-week Phase 3 maintenance study. Subjects who respond to induction will enter the maintenance study; those who do not will receive TD-1473 during extended induction. The safety ...

Phase

2.29 miles

Learn More »

Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis

Patients clinically suspected of NASH will be invited for a screening programme for inclusion in the study. Patients will be screened according to the inclusion and exclusion criteria. Clinical evaluation will be conducted for baseline characteristics and anthropometry measurements such as body weight and height. After clinical evaluations, all baseline ...

Phase

2.29 miles

Learn More »

Assessment of an Orthopedic Surgery Rotation on Musculoskeletal Competency in Emergency Medicine Residency Training

Patient commonly present with orthopedic injuries in the emergency department. Musculoskeletal education has not historically been emphasized in American medical schools, and the effectiveness of an orthopedic surgery rotation has not been well studied in emergency medicine (EM) training. Competency in musculoskeletal education has been tested previously with a validated ...

Phase N/A

3.13 miles

Learn More »

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

The purpose of this study is to characterize the natural history of leukocyte chemotactic factor 2 amyloidotic (ALECT2) disease. In this observational study participants with ALECT2 disease will be enrolled. Participants, who have already reached end-stage renal disease (ESRD), will provide retrospective chart review data and biological specimens at baseline ...

Phase N/A

3.13 miles

Learn More »

Stress Hydrocortisone In Pediatric Septic Shock

Sepsis represents the most common cause of childhood mortality worldwide. In the United States alone, 200 cases of pediatric sepsis are diagnosed each day, with an associated hospital mortality rate of 5-10% and health care expenditures now approaching $5 billion annually. Moreover, nearly one third of children admitted to pediatric ...

Phase

5.37 miles

Learn More »

A Study of CC-95251 a Monoclonal Antibody Directed Against SIRP With Cetuximab in Subjects With Advanced Solid Cancers

Study CC-95251-ST-001 is an open-label, Phase 1, dose escalation (Part A) and expansion (Part B), first-in-human clinical study of CC-95251 in subjects with advanced solid cancers. The dose escalation part (Part A) of the study will be conducted in two stages. Stage 1 will evaluate the safety and tolerability of ...

Phase

8.13 miles

Learn More »

Study of INBRX-105 in Patients With Solid Tumors Hodgkin or Non-Hodgkin Lymphoma

This is a first-in-human, open-label, nonrandomized, two-part Phase 1 trial to determine the safety profile and identify the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of INBRX-105. INBRX-105, a next generation bispecific antibody, targets the human programmed death-ligand 1 (PD-L1) receptor and the human 4-1BB receptor. INBRX-105 ...

Phase

8.13 miles

Learn More »